OLMA — Olema Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Olema Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.068	339	287	204	262
Net Total Receivables	—	—	—	0.319	0.673
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.103	342	291	209	267
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.026	0.075	4.72	3.98	3.26
Other Long Term Assets
Total Assets	0.132	343	296	216	277
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.38	4.58	9.02	16.5	21.6
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.38	4.58	11.4	18.1	23.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.25	338	285	198	254
Total Liabilities & Shareholders' Equity	0.132	343	296	216	277
Total Common Shares Outstanding